Outcomes of Middle Eastern Patients Undergoing Percutaneous Coronary Intervention: The Primary Analysis of the First Jordanian PCI Registry
- PMID: 28584584
- PMCID: PMC5448249
- DOI: 10.4103/1995-705X.206206
Outcomes of Middle Eastern Patients Undergoing Percutaneous Coronary Intervention: The Primary Analysis of the First Jordanian PCI Registry
Abstract
Aim: This is a prospective multicenter registry designed to evaluate the incidence of adverse cardiovascular events in Middle Eastern patients undergoing percutaneous coronary interventions (PCI). The registry was also designed to determine the predictors of poor outcomes in such patients.
Methods and results: We enrolled 2426 consecutive patients who underwent PCI at 12 tertiary care centers in Jordan between January 2013 and February 2014. A case report form was used to record data prospectively at hospital admission, discharge, and 12 months of follow-up. Mean age was 56 ± 11 years, females comprised 21% of the study patients, 62% had hypertension, 53% were diabetics, and 57% were cigarette smokers. Most patients (77%) underwent PCI for acute coronary syndrome. In-hospital and 1-year mortality rates were 0.78% and 1.94%, respectively. Definite or probable stent thrombosis occurred in 9 patients (0.37%) during hospitalization and in 47 (1.94%) at 1 year. Rates of target vessel repeat PCI and coronary artery bypass graft surgery at 1 year were 3.4% and 0.6%, respectively. The multivariate analysis revealed that cardiogenic shock, congestive heart failure, ST-segment deviation, diabetes, and major bleeding were significantly associated with higher risk of 1-year mortality.
Conclusions: In this first large Jordanian registry of Middle Eastern patients undergoing PCI, patients treated were relatively young age population with low in-hospital and 1-year adverse cardiovascular events. Certain clinical features were associated with worse outcomes and may warrant aggressive therapeutic strategies.
Keywords: Acute coronary syndrome; coronary artery disease; middle east; multicenter registry; percutaneous coronary intervention.
Conflict of interest statement
Dr. Ayman Hammoudeh is the recipient of the AstraZeneca grant.
Similar articles
-
Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1).Ann Saudi Med. 2016 Jan-Feb;36(1):17-22. doi: 10.5144/0256-4947.2016.17. Ann Saudi Med. 2016. PMID: 26922683 Free PMC article.
-
Short- and long-term outcomes in Middle Eastern diabetic patients after percutaneous coronary intervention: results from The First Jordanian PCI Registry (JoPCR1).Diabetol Int. 2016 May 3;8(1):30-38. doi: 10.1007/s13340-016-0273-z. eCollection 2017 Mar. Diabetol Int. 2016. PMID: 30603304 Free PMC article.
-
The Impact of Coexistence of Smoking and Diabetes on the Coronary Artery Severity and Outcomes following Percutaneous Coronary Intervention: Results from the 1ST Jordanian PCI Registry.Int J Vasc Med. 2020 Jul 2;2020:7624158. doi: 10.1155/2020/7624158. eCollection 2020. Int J Vasc Med. 2020. PMID: 32695516 Free PMC article.
-
Major bleeding events in Jordanian patients undergoing percutaneous coronary intervention (PCI): Incidence, associated factors, impact on prognosis, and predictability of the CRUSADE bleeding risk score. Results from the First Jordanian PCR (PCR1).Anatol J Cardiol. 2017 Jun;17(6):445-451. doi: 10.14744/AnatolJCardiol.2017.7530. Epub 2017 Mar 22. Anatol J Cardiol. 2017. PMID: 28344216 Free PMC article.
-
Gender differences in risk profile and outcome of Middle Eastern patients undergoing percutaneous coronary intervention.Saudi Med J. 2017 Feb;38(2):149-155. doi: 10.15537/smj.2017.2.16301. Saudi Med J. 2017. PMID: 28133687 Free PMC article.
Cited by
-
The Importance of the First Jordanian Percutaneous Coronary Intervention Registry.Heart Views. 2017 Jan-Mar;18(1):13-14. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_29_17. Heart Views. 2017. PMID: 28584586 Free PMC article. No abstract available.
-
Applying DESyne coronary stent system in patients with ischemic heart disease: experience from Jordan.Med Devices (Auckl). 2018 Nov 26;11:405-412. doi: 10.2147/MDER.S180101. eCollection 2018. Med Devices (Auckl). 2018. PMID: 30538589 Free PMC article.
-
Epidemiological Variation of Acute Myocardial Infarction Relevant to In-Hospital Outcomes-Tertiary Center Experience-Saudi Arabia.J Saudi Heart Assoc. 2020 Aug 1;32(3):340-349. doi: 10.37616/2212-5043.1139. eCollection 2020. J Saudi Heart Assoc. 2020. PMID: 33299774 Free PMC article.
-
Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Less) Study.Vasc Health Risk Manag. 2025 Feb 5;21:39-50. doi: 10.2147/VHRM.S499355. eCollection 2025. Vasc Health Risk Manag. 2025. PMID: 39931041 Free PMC article.
-
Clinical Characteristics and Prognosis of Young Middle Eastern Adults with ST-Elevation Myocardial Infarction: One-Year Follow-Up.Heart Views. 2021 Apr-Jun;22(2):88-95. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_67_20. Epub 2021 Aug 19. Heart Views. 2021. PMID: 34584618 Free PMC article.
References
-
- Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004;364:937–52. - PubMed
-
- Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347–60. - PubMed
-
- Hammoudeh AJ, Izraiq M, Hamdan H, Tarawneh H, Harassis A, Tabbalat R, et al. High-sensitivity C-reactive protein is an independent predictor of future cardiovascular events in Middle Eastern patients with acute coronary syndrome. CRP and prognosis in acute coronary syndrome. Int J Atheroscler. 2008;3:50–5.
-
- Saleh A, Hammoudeh AJ, Hamam I, Khader YS, Alhaddad I, Nammas A, et al. Prevalence and impact on prognosis of glucometabolic states in acute coronary syndrome in a Middle Eastern country: The GLucometabolic abnOrmalities in patients with acute coronaRY syndrome in Jordan (GLORY) study. Int J Diabetes Dev Ctries. 2012;32:37–43.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous